Efficacy and Safety of Autologous Bone Marrow-Derived Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus: A Randomized Placebo-Controlled Study
There is a growing interest in cell-based therapies in T2DM as β-cell failure is progressive and inexorable with the advancing duration of disease. This prospective, randomized, single-blinded placebo-controlled study evaluates the efficacy and safety of autologous bone marrow-derived stem cell tran...
Main Authors: | Anil Bhansali, Premkumar Asokumar, Rama Walia, Shobhit Bhansali, Vivek Gupta, Ashish Jain, Naresh Sachdeva, Rati Ram Sharma, Neelam Marwaha, Niranjan Khandelwal |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2014-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.3727/096368913X665576 |
Similar Items
-
Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up study
by: Anil Bhansali, et al.
Published: (2014-01-01) -
Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity
by: Shobhit Bhansali, et al.
Published: (2017-07-01) -
Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial
by: Girish Parthan, et al.
Published: (2018-07-01) -
Demystifying “steroid withdrawal” during remission in Cushing's disease: Is mineralocorticoid replacement the answer?
by: Nimisha Jain, et al.
Published: (2019-01-01) -
Alterations in Mitochondrial Oxidative Stress and Mitophagy in Subjects with Prediabetes and Type 2 Diabetes Mellitus
by: Shipra Bhansali, et al.
Published: (2017-12-01)